BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12477714)

  • 1. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity.
    Gusterson RJ; Jazrawi E; Adcock IM; Latchman DS
    J Biol Chem; 2003 Feb; 278(9):6838-47. PubMed ID: 12477714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade.
    Gusterson R; Brar B; Faulkes D; Giordano A; Chrivia J; Latchman D
    J Biol Chem; 2002 Jan; 277(4):2517-24. PubMed ID: 11705990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBP/p300 and muscle differentiation: no HAT, no muscle.
    Polesskaya A; Naguibneva I; Fritsch L; Duquet A; Ait-Si-Ali S; Robin P; Vervisch A; Pritchard LL; Cole P; Harel-Bellan A
    EMBO J; 2001 Dec; 20(23):6816-25. PubMed ID: 11726517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1A12S-mediated activation of the adenovirus type 12 E2 promoter depends on the histone acetyltransferase activity of p300/CBP.
    Fax P; Lehmkuhler O; Kuhn C; Esche H; Brockmann D
    J Biol Chem; 2000 Dec; 275(51):40554-60. PubMed ID: 11006273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct serine residues in CBP and p300 are necessary for their activation by phenylephrine.
    Gusterson RJ; Yuan LW; Latchman DS
    Int J Biochem Cell Biol; 2004 May; 36(5):893-9. PubMed ID: 15006641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator.
    Harton JA; Zika E; Ting JP
    J Biol Chem; 2001 Oct; 276(42):38715-20. PubMed ID: 11514574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells.
    Brouillard F; Cremisi CE
    J Biol Chem; 2003 Oct; 278(41):39509-16. PubMed ID: 12888559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene.
    Shankaranarayanan P; Chaitidis P; Kühn H; Nigam S
    J Biol Chem; 2001 Nov; 276(46):42753-60. PubMed ID: 11509556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development.
    Bradney C; Hjelmeland M; Komatsu Y; Yoshida M; Yao TP; Zhuang Y
    J Biol Chem; 2003 Jan; 278(4):2370-6. PubMed ID: 12435739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p300/CBP by early B-cell factor.
    Zhao F; McCarrick-Walmsley R; Akerblad P; Sigvardsson M; Kadesch T
    Mol Cell Biol; 2003 Jun; 23(11):3837-46. PubMed ID: 12748286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity.
    Ray S; Sherman CT; Lu M; Brasier AR
    Mol Endocrinol; 2002 Apr; 16(4):824-36. PubMed ID: 11923478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.
    Chakraborty S; Senyuk V; Sitailo S; Chi Y; Nucifora G
    J Biol Chem; 2001 Nov; 276(48):44936-43. PubMed ID: 11568182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators.
    Chen CJ; Deng Z; Kim AY; Blobel GA; Lieberman PM
    Mol Cell Biol; 2001 Jan; 21(2):476-87. PubMed ID: 11134336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CBP co-activator is a histone acetyltransferase.
    Bannister AJ; Kouzarides T
    Nature; 1996 Dec 19-26; 384(6610):641-3. PubMed ID: 8967953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREB-binding protein/p300 co-activation of crystallin gene expression.
    Chen Q; Dowhan DH; Liang D; Moore DD; Overbeek PA
    J Biol Chem; 2002 Jul; 277(27):24081-9. PubMed ID: 11943779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter.
    Mehra-Chaudhary R; Matsui H; Raghow R
    Biochem J; 2001 Jan; 353(Pt 1):13-22. PubMed ID: 11115394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.
    Vanden Berghe W; De Bosscher K; Boone E; Plaisance S; Haegeman G
    J Biol Chem; 1999 Nov; 274(45):32091-8. PubMed ID: 10542243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.
    Harrod R; Kuo YL; Tang Y; Yao Y; Vassilev A; Nakatani Y; Giam CZ
    J Biol Chem; 2000 Apr; 275(16):11852-7. PubMed ID: 10766811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor-specific modulation of CREB-binding protein acetyltransferase activity.
    Perissi V; Dasen JS; Kurokawa R; Wang Z; Korzus E; Rose DW; Glass CK; Rosenfeld MG
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3652-7. PubMed ID: 10097092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.